Maze Therapeutics, Inc.
MAZENASDAQHealthcare● Active
$23.58
$-0.69(-2.84%)
Market Cap$1.3B
P/E Ratio—
52W High$53.65
52W Low$9.83
Maze Therapeutics, Inc. (MAZE) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MAZE · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $0.00B | $0.17B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | $0.17B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | 100.00% | — | — |
| Operating Expenses | ||||
| R&D Expenses | $0.11B | $0.08B | $0.07B | $0.09B |
| G&A Expenses | $0.03B | $0.03B | $0.02B | $0.02B |
| Total Operating Expenses | $0.14B | $0.11B | $0.10B | $0.11B |
| Operating Income | ($0.14B) | $0.06B | ($0.10B) | ($0.11B) |
| Operating Margin %(computed) | — | 34.38% | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.13B) | $0.05B | ($0.10B) | ($0.11B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.13B) | $0.05B | ($0.10B) | ($0.11B) |
| Net Margin %(computed) | — | 31.18% | — | — |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-3.05 | $0.08 | $-2.29 | $-2.63 |
| Wtd Avg Shares | 0.04B | 0.04B | 0.04B | 0.04B |
| EBITDA | ($0.14B) | $0.06B | ($0.09B) | ($0.11B) |
| EBITDA Margin %(computed) | — | 36.35% | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Maze Therapeutics, Inc. data
About Maze Therapeutics, Inc. (MAZE) Income Statement
Maze Therapeutics, Inc. (MAZE) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, MAZE reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.13B) — a net profit margin of —.
Frequently asked questions
MAZE · 4 questionsMaze Therapeutics, Inc. (MAZE) reported revenue of $0.00B for 2025, down 100.0% year-over-year.
MAZE revenueMAZE salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08